Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Watch and Wait in Rectal Cancer or More Wait and See?

Literature DB >> 32347912

Watch and Wait in Rectal Cancer or More Wait and See?

J Joshua Smith¹, Philip B Paty¹, Julio Garcia-Aguilar¹.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2020 PMID： 32347912 PMCID： PMC7483390 DOI： 10.1001/jamasurg.2020.0226

Source DB: PubMed Journal: JAMA Surg ISSN： 2168-6254 Impact factor: 14.766

× No keyword cloud information.

10 in total

1. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study.

Authors: Ane L Appelt; John Pløen; Henrik Harling; Frank S Jensen; Lars H Jensen; Jens C R Jørgensen; Jan Lindebjerg; Søren R Rafaelsen; Anders Jakobsen
Journal: Lancet Oncol Date: 2015-07-05 Impact factor: 41.316

2. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.

Authors: Claus Rödel; Ullrich Graeven; Rainer Fietkau; Werner Hohenberger; Torsten Hothorn; Dirk Arnold; Ralf-Dieter Hofheinz; Michael Ghadimi; Hendrik A Wolff; Marga Lang-Welzenbach; Hans-Rudolf Raab; Christian Wittekind; Philipp Ströbel; Ludger Staib; Martin Wilhelm; Gerhard G Grabenbauer; Hans Hoffmanns; Fritz Lindemann; Anke Schlenska-Lange; Gunnar Folprecht; Rolf Sauer; Torsten Liersch
Journal: Lancet Oncol Date: 2015-07-15 Impact factor: 41.316

3. Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12.

Authors: Emmanouil Fokas; Michael Allgäuer; Bülent Polat; Gunther Klautke; Gerhard G Grabenbauer; Rainer Fietkau; Thomas Kuhnt; Ludger Staib; Thomas Brunner; Anca-Ligia Grosu; Wolff Schmiegel; Lutz Jacobasch; Jürgen Weitz; Gunnar Folprecht; Anke Schlenska-Lange; Michael Flentje; Christoph-Thomas Germer; Robert Grützmann; Matthias Schwarzbach; Vittorio Paolucci; Wolf O Bechstein; Tim Friede; Michael Ghadimi; Ralf-Dieter Hofheinz; Claus Rödel
Journal: J Clin Oncol Date: 2019-05-31 Impact factor: 44.544

4. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study.

Authors: Maxime J M van der Valk; Denise E Hilling; Esther Bastiaannet; Elma Meershoek-Klein Kranenbarg; Geerard L Beets; Nuno L Figueiredo; Angelita Habr-Gama; Rodrigo O Perez; Andrew G Renehan; Cornelis J H van de Velde
Journal: Lancet Date: 2018-06-23 Impact factor: 79.321

5. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.

Authors: Andrea Cercek; Campbell S D Roxburgh; Paul Strombom; J Joshua Smith; Larissa K F Temple; Garrett M Nash; Jose G Guillem; Philip B Paty; Rona Yaeger; Zsofia K Stadler; Kenneth Seier; Mithat Gonen; Neil H Segal; Diane L Reidy; Anna Varghese; Jinru Shia; Efsevia Vakiani; Abraham J Wu; Christopher H Crane; Marc J Gollub; Julio Garcia-Aguilar; Leonard B Saltz; Martin R Weiser
Journal: JAMA Oncol Date: 2018-06-14 Impact factor: 31.777

6. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer.

Authors: In Ja Park; Y Nancy You; Atin Agarwal; John M Skibber; Miguel A Rodriguez-Bigas; Cathy Eng; Barry W Feig; Prajnan Das; Sunil Krishnan; Christopher H Crane; Chung-Yuan Hu; George J Chang
Journal: J Clin Oncol Date: 2012-04-09 Impact factor: 44.544

7. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results.

Authors: Angelita Habr-Gama; Rodrigo Oliva Perez; Wladimir Nadalin; Jorge Sabbaga; Ulysses Ribeiro; Afonso Henrique Silva e Sousa; Fábio Guilherme Campos; Desidério Roberto Kiss; Joaquim Gama-Rodrigues
Journal: Ann Surg Date: 2004-10 Impact factor: 12.969

8. Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection - A Matched-Controlled Study.

Authors: Britt J P Hupkens; Milou H Martens; Jan H Stoot; Maaike Berbee; Jarno Melenhorst; Regina G Beets-Tan; Geerard L Beets; Stéphanie O Breukink
Journal: Dis Colon Rectum Date: 2017-10 Impact factor: 4.585

9. Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy.

Authors: J Joshua Smith; Paul Strombom; Oliver S Chow; Campbell S Roxburgh; Patricio Lynn; Anne Eaton; Maria Widmar; Karuna Ganesh; Rona Yaeger; Andrea Cercek; Martin R Weiser; Garrett M Nash; Jose G Guillem; Larissa K F Temple; Sree B Chalasani; James L Fuqua; Iva Petkovska; Abraham J Wu; Marsha Reyngold; Efsevia Vakiani; Jinru Shia; Neil H Segal; James D Smith; Christopher Crane; Marc J Gollub; Mithat Gonen; Leonard B Saltz; Julio Garcia-Aguilar; Philip B Paty
Journal: JAMA Oncol Date: 2019-04-11 Impact factor: 31.777

10. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.

Authors: J Joshua Smith; Oliver S Chow; Marc J Gollub; Garrett M Nash; Larissa K Temple; Martin R Weiser; José G Guillem; Philip B Paty; Karin Avila; Julio Garcia-Aguilar
Journal: BMC Cancer Date: 2015-10-23 Impact factor: 4.430

10 in total

4 in total

1. Adoption of Organ Preservation and Surgeon Variability for Patients with Rectal Cancer Does Not Correlate with Worse Survival.

Authors: Jin K Kim; Hannah Thompson; Rosa M Jimenez-Rodriguez; Fan Wu; Francisco Sanchez-Vega; Garrett M Nash; Jose G Guillem; Philip B Paty; Iris H Wei; Emmanouil P Pappou; Maria Widmar; Martin R Weiser; J Joshua Smith; Julio Garcia-Aguilar
Journal: Ann Surg Oncol Date: 2021-10-03 Impact factor: 5.344